Position in AZN
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$415,078
-$25,708 QoQ
Shares Held
2,189
-2.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#912
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Thrive Capital Management, LLC holds $24,319,388 across 7 Drug Manufacturers - General names. AZN ranks #7 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
26,428 | $6,711,919 | |
| 2 | MRK |
Merck & Co., Inc.
|
42,844 | $5,505,454 | |
| 3 | LLY |
ELI LILLY & Co
|
4,356 | $5,224,717 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
34,523 | $4,361,635 | |
| 5 | AMGN |
Amgen Inc
|
4,477 | $1,621,211 | |
| 6 | ABBV |
AbbVie Inc.
|
1,905 | $479,374 | |
| 7 | AZN |
Astrazeneca PLC
This page
|
2,189 | $415,078 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $415,078 | 2,189 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $440,786 | 2,235 | Shares | Sole | 2026-04-27 | |
| No filing history on record for this holder in this stock. | ||||||